Peer Support for Young Women at High Risk for Breast Cancer
Trial Summary
What is the purpose of this trial?
This trial will recruit young adult female relatives (YARs) of male or female carriers of BRCA1/2. YARs who consent to participate will be randomized to either a 3-session peer coach-led telephone counseling intervention or usual care navigation to peer support interventions provided by community organizations that support the hereditary cancer community. Study aims are to 1) Assess intervention effects on distress and decision making outcomes, including uptake of counseling for untested YARs, 2) Identify YARs most likely to engage with and benefit from the intervention, 3) Understand intervention mechanisms. Participants will complete interviews at baseline, 1, 6, and 12 months.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Community peer coaching, Peer Support, Telephone Counseling Intervention, PeACE for young women at high risk for breast cancer?
Research shows that peer support programs can improve emotional well-being and provide valuable psychosocial support for women at risk for or diagnosed with breast cancer. Studies indicate that these programs can help maintain quality of life and reduce psychological distress, especially when delivered through trained peer volunteers.12345
How is the treatment 'Community peer coaching' unique for young women at high risk for breast cancer?
Community peer coaching is unique because it involves one-on-one support from someone who has experienced a similar health journey, providing emotional and informational support through phone calls. This approach focuses on the whole person, aiming to reduce social isolation and improve coping skills, which is different from traditional medical treatments that primarily focus on physical health.12467
Research Team
Suzanne O'Neill
Principal Investigator
Georgetown University
Eligibility Criteria
This trial is for young adult women aged 21-30 who are biological relatives of someone with a BRCA1/2 mutation, indicating high breast cancer risk. Participants must be able to speak English or Spanish and provide informed consent. Men or women carriers of the mutation can also join if they're over 18.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either a 3-session peer coach-led telephone counseling intervention or usual care navigation to peer support interventions
Follow-up
Participants are monitored for distress and decision-making outcomes, including uptake of counseling, with interviews at baseline, 1, 6, and 12 months
Treatment Details
Interventions
- Community peer coaching
- PeACE
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgetown University
Lead Sponsor